Downregulation of USP32 inhibits cell proliferation, migration and invasion in human small cell lung cancer

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Cell Proliferation

• Publication date

  2017-06-09

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/cpr.12343PMID 28597490PMCID PMC6529138
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Downregulation of USP32 inhibits cell proliferation, migration and invasion in human small cell lung cancer

  2017cited by this paper
• Overexpression of USP39 predicts poor prognosis and promotes tumorigenesis of prostate cancer via promoting EGFR mRNA maturation and transcription elongation

  2016cited by this paper
• Regulation of Epithelial-Mesenchymal Transition by E3 Ubiquitin Ligases and Deubiquitinase in Cancer.

  2016cited by this paper
• Targeting ubiquitin-specific protease 22 suppresses growth and metastasis of anaplastic thyroid carcinoma

  2016cited by this paper
• Small Molecule Inhibition of the Ubiquitin-specific Protease USP2 Accelerates cyclin D1 Degradation and Leads to Cell Cycle Arrest in Colorectal Cancer and Mantle Cell Lymphoma Models*

  2016cited by this paper
• Inhibition of Ubiquitin-specific Peptidase 8 Suppresses Adrenocorticotropic Hormone Production and Tumorous Corticotroph Cell Growth in AtT20 Cells

  2016cited by this paper
• Lentivirus mediated silencing of Ubiquitin Specific Peptidase 39 inhibits cell proliferation of human hepatocellular carcinoma cells in vitro

  2015cited by this paper
• Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

  2015cited by this paper
• Inhibition of Ubiquitin-specific Peptidase 8 Suppresses Growth of Gefitinib-resistant Non-small Cell Lung Cancer Cells by Inducing Apoptosis

  2015cited by this paper
• MET and Small-Cell Lung Cancer

  2014cited by this paper
• Ubiquitin-specific protease 14 (USP14) regulates cellular proliferation and apoptosis in epithelial ovarian cancer

  2014cited by this paper
• Gene mutations in small-cell lung cancer (SCLC): results of a panel of 6 genes in a cohort of Italian patients.

  2014cited by this paper
• Prognostic significance of USP22 as an oncogene in papillary thyroid carcinoma

  2013cited by this paper
• Chemotherapy advances in small-cell lung cancer.

  2013cited by this paper
• USP22 Is Useful as a Novel Molecular Marker for Predicting Disease Progression and Patient Prognosis of Oral Squamous Cell Carcinoma

  2012cited by this paper
• The deubiquitination enzyme USP46 functions as a tumor suppressor by controlling PHLPP-dependent attenuation of Akt signaling in colon cancer

  2012cited by this paper
• Identification of genes upregulated in ALK-positive and EGFR/KRAS/ALK-negative lung adenocarcinomas.

  2012cited by this paper
• The ubiquitin-specific protease USP2a enhances tumor progression by targeting cyclin A1 in bladder cancer

  2012cited by this paper
• Genome-scale analysis of DNA methylation in lung adenocarcinoma and integration with mRNA expression

  2012cited by this paper
• Worldwide overview of the current status of lung cancer diagnosis and treatment.

  2012cited by this paper
• Atypical Mechanism of NF-κB activation by TRE17/Ubiquitin-Specific Protease 6 (USP6) oncogene and its requirement in tumorigenesis

  2011cited by this paper
• USP10 regulates p53 localization and stability by deubiquitinating p53.

  2010cited by this paper
• USP32 is an active, membrane-bound ubiquitin protease overexpressed in breast cancers

  2010cited by this paper
• Copy number alterations that predict metastatic capability of human breast cancer.

  2009cited by this paper
• Targeting ubiquitin specific proteases for drug discovery.

  2008cited by this paper
• Gene Expression Signature of Cigarette Smoking and Its Role in Lung Adenocarcinoma Development and Survival

  2008cited by this paper
• Small cell lung cancer: have we made any progress over the last 25 years?

  2007cited by this paper
• The regulation of cyclin D1 degradation: roles in cancer development and the potential for therapeutic invention

  2007cited by this paper
• Clinicopathological and prognostic significance of EGFR, VEGF, and HER2 expression in cholangiocarcinoma

  2007cited by this paper
• The isopeptidase USP2a protects human prostate cancer from apoptosis.

  2006cited by this paper
• Establishment of the epithelial-specific transcriptome of normal and malignant human breast cells based on MPSS and array expression data

  2006cited by this paper
• Calcium/Calmodulin Regulates Ubiquitination of the Ubiquitin-specific Protease TRE17/USP6*

  2005cited by this paper
• A genomic and functional inventory of deubiquitinating enzymes.

  2005cited by this paper
• The isopeptidase USP2a regulates the stability of fatty acid synthase in prostate cancer.

  2004cited by this paper
• The Tre2 (USP6) oncogene is a hominoid-specific gene

  2003cited by this paper
• Deubiquitinating enzymes--the importance of driving in reverse along the ubiquitin-proteasome pathway.

  2003cited by this paper
• Ras–GAP SH3 domain binding protein (G3BP) is a modulator of USP10, a novel human ubiquitin specific protease

  2001cited by this paper

• Spotlights on ubiquitin-specific proteases in lung cancer: from multifaceted pathophysiological mechanisms to potential therapeutic targets

  2026cites this paper
• Single-cell RNA sequence analysis reveals USP32 as a therapeutic target to mitigate PD-L1-driven colorectal tumorigenesis in vitro and in vivo

  2026cites this paper
• Huib32: A Potent and Selective USP32 Inhibitor Modulating Endosomal Processes and Advancing Cell-Permeable USP32 Probes

  2025cites this paper
• USP32 facilitates tumor development and is correlated with poor clinical outcomes in hepatocellular carcinoma patients and is modulated by the E2F7/miR-218-5p axis

  2025cites this paper
• USP32 stabilizes SEMA4C to promote malignant behavior of colon cancer cells.

  2025cites this paper
• Molecular regulation by ubiquitin-specific proteases (USPs) in HCC: cell cycle, oncogenic signaling, and beyond

  2025influential citation
• USP32 promotes temporomandibular joint osteoarthritis by modulating PKM2 stability and glycolytic metabolism in chondrocytes

  2025cites this paper
• USP32 Promotes Colorectal Carcinoma Progression Through Activating NF‐κB Signalling Pathway

  2025cites this paper
• Immune Surveillance in Chronic Myeloid Leukemia: Tumor Antigen Expression and CD8+ T Cell Function in the Context of Treatment- Free Remission

  2025cites this paper
• USP32 facilitates non-small cell lung cancer progression via deubiquitinating BAG3 and activating RAF-MEK-ERK signaling pathway

  2024cites this paper
• Understanding The Regulatory Role of USP32 and SHMT2 in The Progression of Gastric Cancer

  2023cites this paper
• Platelet-derived circRNAs signature in patients with gastroenteropancreatic neuroendocrine tumors

  2023cites this paper
• USP32 deubiquitinase: cellular functions, regulatory mechanisms, and potential as a cancer therapy target

  2023cites this paper
• High USP32 expression contributes to cancer progression and is correlated with immune infiltrates in hepatocellular carcinoma

  2023cites this paper
• Targeting MET endocytosis or degradation to overcome HGF-induced gefitinib resistance in EGFR-sensitive mutant lung adenocarcinoma.

  2023cites this paper
• Roles of the hsa_circ_0013880/USP32/Rap1b axis in the proliferation and apoptosis of acute myeloid leukemia cells

  2023cites this paper
• USP32-regulated LAMTOR1 ubiquitination impacts mTORC1 activation and autophagy induction.

  2022cites this paper
• LINC01204 Negatively Regulates the Effect of MiR-214 on Lung Cancer Cell Apoptosis, Migration, Invasion and Radio-sensitivity

  2022cites this paper
• Identification of ubiquitin-specific protease 32 as an oncogene in glioblastoma and the underlying mechanisms

  2022cites this paper
• Targeting protein kinases benefits cancer immunotherapy.

  2022cites this paper
• The Deubiquitinase USP13 Maintains Cancer Cell Stemness by Promoting FASN Stability in Small Cell Lung Cancer

  2022cites this paper
• Genetic variation as a long-distance modulator of RAD21 expression in humans

  2021cites this paper
• USP32 confers cancer cell resistance to YM155 via promoting ER-associated degradation of solute carrier protein SLC35F2

  2021cites this paper
• Altered pathways in methylome and transcriptome longitudinal analysis of normal weight and bariatric surgery women

  2020cites this paper
• Ubiquitin, SUMO, and Nedd8 as Therapeutic Targets in Cancer.

  2020cites this paper
• Ubiquitin-specific proteases as targets for anticancer drug therapies

  2020cites this paper
• Small molecule inhibitors targeting the PD-1/PD-L1 signaling pathway

  2020cites this paper
• USP32 promotes tumorigenesis and chemoresistance in gastric carcinoma via upregulation of SMAD2

  2020cites this paper
• Pol-miR-363-3p plays a significant role in the immune defense of Japanese flounder Paralichthys olivaceus against bacterial and viral infection.

  2020cites this paper
• Deubiquitinating enzymes as cancer biomarkers: new therapeutic opportunities?

  2019cites this paper
• MicroRNA let-7a inhibits proliferation of breast cancer cell by downregulating USP32 expression

  2019cites this paper
• Functional analysis of deubiquitylating enzymes in tumorigenesis and development.

  2019cites this paper
• USP32 regulates late endosomal transport and recycling through deubiquitylation of Rab7

  2019cites this paper
• Downregulation of USP32 inhibits cell proliferation, migration and invasion in human small cell lung cancer

  2017cites this paper